10 Dec 2025
Antibody therapy clears traces of multiple myeloma
A phase 2 trial found that an antibody drug, linvoseltamab, removed detectable disease in patients with multiple myeloma using very sensitive bone marrow tests. Researchers report acceptable safety and will expand the trial.